SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-101703
Filing Date
2015-03-23
Accepted
2015-03-23 16:06:05
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d851682d10k.htm 10-K 980113
2 EX-23.1 d851682dex231.htm EX-23.1 1539
3 EX-31.1 d851682dex311.htm EX-31.1 8365
4 EX-31.2 d851682dex312.htm EX-31.2 8103
5 EX-32.1 d851682dex321.htm EX-32.1 5360
12 GRAPHIC g851682g41w55.jpg GRAPHIC 68170
  Complete submission text file 0001193125-15-101703.txt   6435855

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldx-20141231.xml EX-101.INS 640466
7 XBRL TAXONOMY EXTENSION SCHEMA aldx-20141231.xsd EX-101.SCH 55378
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20141231_cal.xml EX-101.CAL 66551
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20141231_def.xml EX-101.DEF 253364
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20141231_lab.xml EX-101.LAB 489262
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20141231_pre.xml EX-101.PRE 367474
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36332 | Film No.: 15719265
SIC: 2834 Pharmaceutical Preparations